Litigation Details for Azurity Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2023)
✉ Email this page to a colleague
Azurity Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2023)
| Docket | ⤷ Start Trial | Date Filed | 2023-09-01 |
| Court | District Court, D. Delaware | Date Terminated | 2023-11-01 |
| Cause | Motion to Quash | Assigned To | Mitchell S. Goldberg |
| Jury Demand | None | Referred To | |
| Patents | 10,039,745; 10,154,987; 10,772,868; 10,786,482; 11,040,023; 11,141,405; 11,173,141; 9,669,008; 9,808,442 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Azurity Pharmaceuticals, Inc. v. Bionpharma Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Details for Azurity Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-09-01 | External link to document | |||
| 2023-09-01 | 2 | Attachment A to Deposition Subpoena | Azurity,patents" means each of United States Patent Nos. 9,669,008, 9,808,442, 10,039,745, 10,154,987…counsel on the other hand, concerning the Azurity patents. …2023 1 November 2023 1:23-mc-00396 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
